Yujing Xu

Ms. Yujing Xu


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 May 2019 in Cancer Cell International
Verified
Journal Article
Open access
PDF file
Dehui XuDehui Xu
Dehui Xu
NNNing Ning
Ning Ning
YXYujing Xu
Yujing Xu
BWBingchuan Wang
Bingchuan Wang
QCQingjie Cui
Qingjie Cui
MKMichael G Kong
Michael G Kong
Acute myeloid leukemia (AML) is a typically fatal malignancy and new drug and treatment need to be developed for a better survival outcome. Cold atmospheric plasma (CAP) is a novel technology, which has been widely applied in biomedicine, especially in various of cancer treatment. However, the changes in cell metabolism after CAP treatment of leukemia cells have been rarely studied. In this study, we investigated the metabolite profiling of plasma treatment on leukemia cells based on Gas Chromatography Tandem Time-of-Flight Mass Spectrometry (GC-TOFMS). Simultaneously, we conducted a series of bioinformatics analysis of metabolites and metabolic pathways with significant differences after basic data analysis. 800 signals were detected by GC–TOF mass-spectrometry and then evaluated using PCA and OPLS-DA. All the differential metabolites were listed and the related metabolic pathways were analyzed by KEGG pathway. The results showed that alanine, aspartate and glutamate metabolism had a significant change after plasma treatment. Meanwhile, d-glutamine and d-glutamate metabolism were significantly changed by CAP. Glutaminase activity was decreased after plasma treatment, which might lead to glutamine accumulation and leukemia cells death. We found the above two metabolic pathways vulnerable to plasma treatment, which might result in leukemia cells death and might be the cornerstone of further exploration of plasma treatment targets.

14 June 2016 in Scientific Reports
Verified
Journal Article
Open access
PDF file
Dehui XuDehui Xu
Dehui Xu
BWBiqing Wang
Biqing Wang
YXYujing Xu
Yujing Xu
ZCZeyu Chen
Zeyu Chen
QCQinjie Cui
Qinjie Cui
MKMichael G Kong
Michael G Kong
This study reports the potential of cold atmospheric plasma (CAP) as a versatile tool for delivering oligonucleotides into mammalian cells. Compared to lipofection and electroporation methods, plasma transfection showed a better uptake efficiency and less cell death in the transfection of oligonucleotides. We demonstrated that the level of extracellular aqueous reactive oxygen species (ROS) produced by gas plasma is correlated with the uptake efficiency and that this is achieved through an increase of intracellular ROS levels and the resulting increase in cell membrane permeability. This finding was supported by the use of ROS scavengers, which reduced CAP-based uptake efficiency. In addition, we found that cold atmospheric plasma could transfer oligonucleotides such as siRNA and miRNA into cells even in 3D cultures, thus suggesting the potential for unique applications of CAP beyond those provided by standard transfection techniques. Together, our results suggest that cold plasma might provide an efficient technique for the delivery of siRNA and miRNA in 2D and 3D culture models.

16 May 2024 in Journal of Physics D: Applied Physics
Verified
Journal Article
Closed access
JZJishen Zhang
Jishen Zhang
TWTong Wu
Tong Wu
XJXixi Jing
Xixi Jing
SXShengduo Xu
Shengduo Xu
Zifeng WangZifeng Wang
Zifeng Wang
MRMingzhe Rong
Mingzhe Rong
The application of cold atmospheric plasma (CAP) in cancer therapy has recently received extensive attention. However, researchers have mainly studied the effects of CAP on plasma-irradiated cancer cells and have not determined whether CAP affects surrounding or distant non-irradiated cancer cells. Here, the viability and intracellular reactive oxygen species levels of plasma-irradiated and non-irradiated cancer cells were monitored in vitro. Our results showed that CAP may induce plasma-irradiated cancer cells (A549 cells, A375 cells, J82 cells and HT29 cells) to secrete soluble factors into the cell culture medium, which can transmit plasma-induced anticancer effects from plasma-irradiated cancer cells to non-irradiated cancer cells. Our research confirmed that plasma-induced anticancer effects can be transmitted between cancer cells.

25 July 2024 in Plasma Processes and Polymers
Verified
Journal Article
Closed access
JZJishen Zhang
Jishen Zhang
SXShengduo Xu
Shengduo Xu
JCJinkun Chen
Jinkun Chen
WYWeiji Yang
Weiji Yang
TWTong Wu
Tong Wu
MRMingzhe Rong
Mingzhe Rong

4 November 2025 in Plasma Processes and Polymers
Verified
Journal Article
Closed access
YXYujing Xu
Yujing Xu
JCJinkun Chen
Jinkun Chen
HZHao Zhang
Hao Zhang
XJXixi Jing
Xixi Jing
ZWZewei Wang
Zewei Wang
PCPaul Chu
Paul Chu

3 November 2019 in BioMed Research International
Verified
Journal Article
Open access
PDF file
YYYanjie Yang
Yanjie Yang
Dehui XuDehui Xu
Dehui Xu
NNNing Ning
Ning Ning
YXYujing Xu
Yujing Xu
Cold atmospheric plasma (CAP) is a novel technology, which has been widely applied in biomedicine, especially in wound healing, dermatological treatment, hemostasis, and cancer treatment. In most cases, CAP treatment will interact with innumerable blood capillaries. Therefore, it is important and necessary to understand the effects of CAP treatment on endothelial cell metabolism. In this study, the metabolite profiling of plasma treatment on endothelial cells was measured by gas chromatography tandem time-of-flight mass spectrometry (GC-TOF-MS). We found that 695 signals (metabolites) were detected by GC-TOF-MS and then evaluated using orthogonal projections to latent structures discriminant analysis (OPLS-DA). All the differential metabolites were listed, and proline and xanthosine were the two of the most downregulated metabolites by plasma treatment. By comprehensive metabolic pathway analysis with the KEGG pathway, we showed that alanine, aspartate, glutamate, and purine metabolism pathways were the most significantly suppressed after gas plasma treatment in human endothelial cells. Our finding gives an overall picture of the metabolic pathways affected by plasma treatment in endothelial cells.